---
title: "STOCKS | Bambusa Therapeutics Falls 7% on Debut After $168.9 Million IPO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303780537.md"
description: "Bambusa Therapeutics Inc. shares fell 7% in their trading debut after the early-stage biotech raised $168.9 million in a US initial public offering, Bloomberg reported. The company focuses on dermatology and autoimmune diseases."
datetime: "2026-10-30T16:20:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303780537.md)
  - [en](https://longbridge.com/en/news/303780537.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303780537.md)
generator: "portal-rs"
---

# STOCKS | Bambusa Therapeutics Falls 7% on Debut After $168.9 Million IPO

Bambusa Therapeutics Inc. shares fell 7% in their trading debut after the early-stage biotech raised $168.9 million in a US initial public offering, Bloomberg reported. The company focuses on dermatology and autoimmune diseases.

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [BUZZ-Bambusa Therapeutics poised to open higher in debut after upsized $169 million US IPO](https://longbridge.com/en/news/303770692.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [Have Insiders Sold Fastly Shares Recently?](https://longbridge.com/en/news/306369355.md)
- [Nasdaq (NDAQ) Just Gave Investors Something To Think About](https://longbridge.com/en/news/306370324.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**